HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Young-Soon Na Selected Research

Histones (Histone)

4/2014Phase I and pharmacodynamic study of vorinostat combined with capecitabine and cisplatin as first-line chemotherapy in advanced gastric cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Young-Soon Na Research Topics

Disease

10Neoplasms (Cancer)
01/2020 - 01/2009
7Stomach Neoplasms (Stomach Cancer)
10/2020 - 04/2014
3Multiple Myeloma
04/2014 - 02/2011
2Neoplasm Metastasis (Metastasis)
08/2019 - 04/2014
2Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
09/2017 - 01/2015
2Colorectal Neoplasms (Colorectal Cancer)
01/2012 - 01/2009
2Colonic Neoplasms (Colon Cancer)
08/2011 - 12/2010
1Renal Cell Carcinoma (Grawitz Tumor)
03/2015
1Adenocarcinoma
04/2014
1Sarcoma (Soft Tissue Sarcoma)
07/2012
1Lung Neoplasms (Lung Cancer)
01/2012
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2012
1Dementia (Dementias)
12/2006
1Parkinson Disease (Parkinson's Disease)
12/2006
1Acquired Immunodeficiency Syndrome (AIDS)
06/2004

Drug/Important Bio-Agent (IBA)

5Proteins (Proteins, Gene)FDA Link
07/2012 - 06/2004
4Histone Deacetylase InhibitorsIBA
05/2016 - 12/2010
4Irinotecan (Camptosar)FDA LinkGeneric
01/2012 - 01/2009
3Imatinib Mesylate (Gleevec)FDA Link
01/2020 - 01/2015
3VorinostatFDA Link
05/2016 - 08/2011
2Tyrosine Kinase InhibitorsIBA
01/2020 - 09/2017
2PlatinumIBA
08/2019 - 05/2017
2Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA
05/2017 - 06/2015
2Capecitabine (Xeloda)FDA Link
05/2016 - 04/2014
2Biomarkers (Surrogate Marker)IBA
05/2016 - 03/2015
2Cisplatin (Platino)FDA LinkGeneric
05/2016 - 04/2014
2Cetuximab (Erbitux)FDA Link
01/2012 - 01/2009
2ErbB Receptors (EGF Receptor)IBA
01/2012 - 01/2012
1Paclitaxel (Taxol)FDA LinkGeneric
10/2020
1RamucirumabIBA
10/2020
1BilirubinIBA
08/2019
1Sunitinib (Sutent)FDA Link
09/2017
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
09/2017
1regorafenibIBA
09/2017
1Formaldehyde (Formol)FDA Link
05/2017
1ParaffinIBA
05/2017
1Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
05/2017
1Histone Deacetylases (Histone Deacetylase)IBA
05/2016
1EverolimusFDA Link
03/2015
1Tyrosine (L-Tyrosine)FDA Link
04/2014
1Histones (Histone)IBA
04/2014
1Transcription Factors (Transcription Factor)IBA
04/2014
1Serine (L-Serine)FDA Link
04/2014
1SesquiterpenesIBA
03/2014
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
03/2014
1Anti-Inflammatory Agents (Anti-Inflammatories)IBA
03/2014
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
07/2012
1SurvivinIBA
01/2012
1Apoptosis Regulatory ProteinsIBA
01/2012
1Monoclonal AntibodiesIBA
01/2012
1sepantroniumIBA
01/2012
1thymidine kinase 1IBA
08/2011
1belinostatIBA
08/2011
1decursinIBA
02/2011
1Bortezomib (Velcade)FDA Link
02/2011
1Oxaliplatin (Eloxatin)FDA LinkGeneric
12/2010
1Fluorouracil (Carac)FDA LinkGeneric
12/2010
1Proline (L-Proline)FDA Link
07/2010
1Codon (Codons)IBA
01/2009
1alpha-SynucleinIBA
12/2006
1Dopamine (Intropin)FDA LinkGeneric
12/2006

Therapy/Procedure

8Drug Therapy (Chemotherapy)
05/2017 - 01/2009
2Therapeutics
10/2020 - 01/2009
1Aftercare (After-Treatment)
01/2020
1Combination Drug Therapy (Combination Chemotherapy)
08/2019
1Radiotherapy
08/2011